CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Clindamycin Phosphate In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?
Clindamycin Phosphate In Dextrose 5% In Plastic Container is a drug marketed by Abbott Labs and Baxter Hlthcare and is included in two NDAs.
The generic ingredient in CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clindamycin Phosphate In Dextrose 5% In Plastic Container
A generic version of CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as clindamycin phosphate by ALMAJECT on July 24th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 27 |
Clinical Trials: | 30 |
DailyMed Link: | CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Daré Bioscience, Inc. | Phase 1 |
Memorial Sloan Kettering Cancer Center | Phase 2 |
Daré Bioscience, Inc. | Phase 3 |
See all CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials